Jacob Ph.d Vanlandingham - 14 Oct 2022 Form 4 Insider Report for Odyssey Health, Inc. (ODYY)

Role: Related Party
Signature: /s/ Christine M. Farrell, Attorney-in-Fact for Jacob Vanlandingham
Issuer symbol: ODYY
Transactions as of: 14 Oct 2022
Net transactions value: +$318,000
Form type: 4
Filing time: 19 Oct 2022, 21:27:09 UTC
Previous filing: 14 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ODYY	Stock Option (Right to Buy)	Award	$318,000	+1,000,000	+91%	$0.3180	2,100,000	14 Oct 2022	Common Stock	1,000,000	$0.3180	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vesting Schedule 250,000 upon signing; 250,000 upon an IND being approved by the FDA for Phase 2; 250,000 upon a listing on a national exchange (Nasdaq, NYSE); and 250,000 one year from Effective Date.